Evidence map›Paper›PMID 21372145›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

The stimulation of HSD17B7 expression by estradiol provides a powerful feed-forward mechanism for estradiol biosynthesis in breast cancer cells.

Aurora Shehu, Constance Albarracin, Y Sangeeta Devi, Kristin Luther, Julia Halperin, Jamie Le, Jifang Mao, Rachel W Duan, Jonna Frasor, Geula Gibori

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Alternative splicing of transposable elements in human breast cancer.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Targeting macrophagic 17Acta pharmaceutica Sinica. B · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Aurora ShehuDepartment of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
Constance Albarracin
Y Sangeeta Devi
Kristin Luther
Julia Halperin
Jamie Le
Jifang Mao
Rachel W Duan
Jonna Frasor
Geula Gibori
University of Illinois Chicago · USThe University of Texas MD Anderson Cancer Center · US

Funding

REGULATION OF LUTEAL FUNCTION IN THE PREGNANT RATR01HD011119 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GIBORI, GEULA · 1985 to 2009
$2.3M
FUNCTION OF THE DECIDUAL TISSUER01HD012356 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GIBORI, GEULA · 1986 to 2007
$1.8M
Crosstalk between estrogen receptor and NFkB in target gene regulationR01CA130932 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FRASOR, JONNA · 2009 to 2013
$1.5M
REGULATION OF LUTEAL FUNCTIONR37HD011119 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GIBORI, GEULA · 1988 to 1997
–
NCI NIH HHS CA130932NCI NIH HHS R01 CA130932NICHD NIH HHS HD11119NICHD NIH HHS HD12356NICHD NIH HHS R01 HD011119NICHD NIH HHS R01 HD012356NICHD NIH HHS R37 HD011119
6 · The paper itself

Abstract

Our laboratory has previously cloned and purified an ovarian protein found to be a novel 17β-hydroxysteroid dehydrogenase type 7 enzyme (HSD17B7) (formerly prolactin receptor-associated protein) that converts the weak estrogen, estrone, to the highly potent estradiol. The regulation of this enzyme has not yet been explored. In this report, we show high expression of HSD17B7 in human ductal carcinoma and breast cancer cell lines and present evidence for a strong up-regulation of this enzyme by estradiol at the level of mRNA, protein expression, and promoter activity in MCF-7 cells. The effect of estradiol is mediated by estrogen receptor (ER)α, whereas ERβ prevents this stimulation. ER antagonists, ICI 182,780 and 4-hydroxytamoxifen, prevent estradiol-induced stimulation of the endogenously expressed HSD17B7, suggesting that these inhibitors not only block estradiol action but also its production. We have identified a -185-bp region of the hsd17b7 promoter that is highly conserved among rat, mouse, and human and confers regulation by estradiol in MCF-7 cells. This region is devoid of a classical estradiol-response element but contains a nuclear factor 1 (NF1) site that is essential for estradiol action. We found that estradiol stimulates the recruitment and DNA binding of NF1 to this region of the hsd17b7 promoter. Furthermore, knockdown of NF1 family members, NF1B, NF1A, and NF1X, completely prevents induction of this gene by estradiol. In summary, our findings demonstrate that estradiol stimulates HSD17B7 transcriptional activity in breast cancer cells through a novel mechanism requiring NF1 and strongly suggest a positive feedback mechanism to increase local estradiol synthesis causing growth of estrogen-dependent breast cancers.

Indexed as

AnimalsBreast NeoplasmsCarcinoma, Ductal, BreastCell Cycle ProteinsCell Line, TumorEstradiolEstrogen Receptor alphaEstrogen Receptor betaFeedback, PhysiologicalFemaleGene Expression Regulation, NeoplasticHumansImmune SeraMammary Glands, AnimalMiceNeoplasms, Hormone-DependentCell Cycle ProteinsESR1 protein, humanEstradiolEstrogen Receptor alphaEstrogen Receptor betaImmune SeraNFI Transcription FactorsS100A6 protein, humanS100 Calcium Binding Protein A6S100 Proteins

Identifiers

PMID21372145
PMCPMC3082328
OpenAlexW2074217425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.